Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: chronic pain

Lost and found

Understanding the Role of Uric Acid in Gout

Ruth Jessen Hickman, MD  |  September 6, 2022

From the first substantial argument in the 19th century that uric acid played a role in gout, it took about 100 years for the medical community to accept its role in triggering acute inflammatory gout attacks. Two papers, both published in 1962, helped demonstrate the link between uric acid and acute gout attacks, quickly opening…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:GoutGout Resource CenterLost & FoundUric acid

Case Report: CPPD Presenting as Pseudosepsis

Hassan Fakhoury, BS, Erin Chew, MD, & Narender Annapureddy, MBBS  |  September 6, 2022

Calcium pyrophosphate crystal deposition disease (CPPD) is an arthritis caused by the accumulation of calcium pyrophosphate crystals. Despite a prevalence of 4–7% among the adult population in Europe and the U.S., it has remained a relatively under-recognized disease owing to its many clinical presentations.1 CPPD may cause an acute mono/oligoarthritis, which may mimic gout or…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:calcium pyrophosphate deposition diseaseGoutpseudosepsisseptic arthritis

Sacroiliitis on MRI: axSpA or Another Cause?

Arthritis & Rheumatology  |  August 31, 2022

Magnetic resonance imaging (MRI) is the gold standard imaging modality for the detection of sacroiliitis, a hallmark of axial spondyloarthritis (axSpA). However, the specificity of MRI for axSpA has been questioned. Renson et al. found that structural MRI-detected SI joint lesions are frequently seen in healthy individuals.

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Arthritis & RheumatologyAS Resource Centeraxial spondyloarthritis (SpA)imagingMagnetic resonance imaging (MRI)MRIResearchsacroiliitis

Late Summer 2022’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  August 14, 2022

Charles G. Helmick III, MD, Retires After 42 Years with the CDC On Dec. 31, 2021, after 42 years of service, Charles (Chad) G. Helmick III, MD (Capt., USPHS, Ret.), officially retired from the Centers for Disease Control and Prevention. He joined the CDC in 1979, when Jimmy Carter was president, and served through eight…

Filed under:AwardsProfessional TopicsProfiles Tagged with:Dr. Amanda S. AlexanderDr. Cecilia ChungDr. Charles G. Helmick

A Clear Vision: Understanding the Connection Between Ophthalmology & Rheumatic Disease

Jason Liebowitz, MD, FACR  |  August 11, 2022

Meghan Berkenstock, MD, summarized key clinical pearls related to uveitis and rheumatic diseases during a session of the 18th Annual Advances in the Diagnosis & Treatment of the Rheumatic Diseases symposium.

Filed under:ConditionsMeeting Reports Tagged with:Annual Advances in the Diagnosis and Treatment of the Rheumatic DiseaseseyesophthalmologyRheumatic DiseaseRheumatoid Arthritis (RA)SarcoidosisUveitis

Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

Samantha C. Shapiro, MD  |  July 22, 2022

Glucocorticoids remain a prominent part of care for many patients with SLE but can have toxic side effects; this EULAR 2022 session discussed one institution’s approach to lower the dosage.

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:GlucocorticoidsHCQHydroxychloroquine (HCQ)prednisoneSLEsystemic lupus erythematosus (SLE)

A Prescription for Mindfulness

Dana DiRenzo, MD, MHS  |  July 13, 2022

The prescription is a powerful tool for a physician. As rheuma­tologists, we prescribe many things—drugs, physical therapy, durable medical equipment—but what about stress reduction? We are very specific about times of day to take medications and in what manner. Patients ask: With or without food? With other medications? Before or after other prescribed medications? If…

Filed under:AppsEducation & TrainingTechnology Tagged with:meditationmindfulnessself-managementStress

Case Report: Dermato-Neuro Syndrome Recurrence after a Viral Infection

Case Report: Dermato-Neuro Syndrome Recurrence after a Viral Infection

Fazila Aseem, MD, MPH, Alexander D. Jeffs, MD, Enid Y. Sun, MD, MPH, Randaline R. Barnett, MD, Courtney Blodgett, AG-ACNP, Winnie Lau, MD, Casey Olm-Shipman, MD, MS, Matthew F. Sharrock, MD, Rhonda Cadena, MD, Yueh. Z. Lee, MD, PhD, Alfredo C. Rivadeneira, MD, & Clio A. Rubinos, MD, MS  |  July 13, 2022

Scleromyxedema is a primary cutaneous mucinosis characterized by a diffuse and generalized papular skin eruption of mucinous deposits throughout the upper dermis. In addition to dermatologic manifestations, scleromyxedema may involve the cardiopulmonary, gastrointestinal, renal and nervous systems. Dermato-neuro syndrome (DNS) is a rare, severe neurologic complication of scleromyxedema.1,2 The pathogenesis of DNS is unknown, but…

Filed under:ConditionsSystemic Sclerosis Tagged with:case reportCOVID-19Dermato-Neuro SyndromeFellowsScleromyxedema

OA Prevalence Primarily on the Rise

Arthritis & Rheumatology  |  June 29, 2022

Background & Objectives Worldwide, osteoarthritis (OA) is a highly prevalent, chronic joint disease that causes pain, disability and loss of function. Global trends demonstrated an increase of more than 100% in years lived with disability due to OA from 1990 to 2019. However, no nonsurgical intervention exists to prevent, halt or even delay OA progression….

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis & RheumatologydisabilityOsteoarthritisosteoarthritis (OA)PrevalenceResearch

Kidney Pathology for the Rheumatologist: Tips from an Expert

Samantha C. Shapiro, MD  |  June 18, 2022

Renal biopsy is a valuable tool for the accurate diagnosis and management of patients with kidney involvement due to rheumatic disease. Agnes B. Fogo, MD, shared her expertise on renal pathology and insights into what rheumatologists should know, during a session at the 2022 ACR Education Exchange.

Filed under:ConditionsEducation & TrainingMeeting ReportsOther ACR meetings Tagged with:ACR Education Exchangekidneykidney diseaseLupus nephritispathology

  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 106
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences